Rafee Talukder

@HadidiSamer RIP. He was an amazing mentor and one of my primary inspiration for becoming a hematologist and oncologist

Deeply saddened to share that Dr. Mark Udden has passed away. He was an extraordinary mentor who shaped my career and touched countless lives through his dedication to teaching. His leadership of the ABIM Hematology Board elevated our entire field. My deepest condolences to his family and friends. His legacy of excellence, compassion, and generosity will live on in all of us he taught. We've lost a giant in hematology @ABIMcert @ASH_hematology @bcmhouston @BCMHemeOnc

⭐️Loved this informative talk by Dr. Hiba Khan @fredhutch . Updated table on the PARP inhibitor combination trials . Also a very thoughtful discussion for treatment escalation candidates for non-metastatic prostate cancer. @PGrivasMDPhD @EvanHallMD @MartinMaMDPhD @rafee_talukder @DRBakaloudiMD

⭐️Dr. Scott Tykodi @fredhutch gives a masterful discussion on the only adjuvant study that was positive for RCC. He also gives an intriguing discussion of the use of NIVO/IPI for 1st line metastatic RCC with favorable risk . @PGrivasMDPhD @rafee_talukder @oncodaily

I am delighted to share our manuscript evaluating Tumor Mutational Burden (TMB) and Microsatellite Instability (MSI) in pts with #Urothelialcancer treated with ICIs Thanks to our amazing team @PGrivasMDPhD @arkhaki @rafee_talukder @UW @fredhutch sciencedirect.com/science/articl… (1/7)

⭐️My good friend @PGrivasMDPhD and I talk about the importance of Mentorship in Oncology. We discuss people we admire such as Dr. Neeraj Agarwal and Dr. Monty Pal for being outstanding mentors. Also we discuss @DRBakaloudiMD journey to win the @ConquerCancerFd merit award. @neerajaiims @montypal @rafee_talukder @koshkin85 @ShubhAgrawalMD @AmandaNizamMD @NazliDizman @crisbergerot @YLeyfman @OncLive

Incredibly honored to receive one of the @ConquerCancerFd @ASCO merit awards and be part of this amazing group of brilliant minds ⭐️ Thankful to my mentors @PGrivasMDPhD @JLWrightMD and team @arkhaki @rafee_talukder @UW @fredhutch

@TumorBoardTues @PGrivasMDPhD @IntegrityCE @JanssenUS @AstraZeneca @shilpaonc @brian_rini @DrRanaMcKay @galsky @arkhaki @tompowles1 @AmandaNizamMD @neerajaiims @AarmstrongDuke @sonpavde @arvinkgeorge @AzadOncology @jberchuck @Ecastromarcos @JonAnker1 @Prof_Nick_James @ScotNiglio @umangtalking 15/15 #TumorBoardTuesday Extra attention & discussion for shared decision making for specific comorbidities: 🦵≥G2 neuropathy Uncontrolled DM Liver cirrhosis 🫘GFR <30 mL/min Hx of autoimmune dx 💉Prior IO in localized dx What 💉 would you use in 2L post EV+P? Next TBT?💁

@TumorBoardTues @PGrivasMDPhD @IntegrityCE @JanssenUS @AstraZeneca @shilpaonc @brian_rini @DrRanaMcKay @galsky @arkhaki @tompowles1 @AmandaNizamMD @neerajaiims @AarmstrongDuke @sonpavde @arvinkgeorge @AzadOncology @jberchuck @Ecastromarcos @JonAnker1 @Prof_Nick_James @ScotNiglio @umangtalking 14/15 #TumorBoardTuesday 🧑‍🏫Which regimen for 1L aUC? Detailed discussion of data, benefits vs risks/AEs, between patients & providers! Education, BSC and multi-d input very important! (Pall care, PT/OT, Pharm, etc.) for optimal mgmt of AEs Based on all 📚: EV + P SOC 1L (if fit)

#TumorBoardTuesday 📢Join us Tuesday, 03-05-24 at 8PM ET as @PGrivasMDPhD & @rafee_talukder serve as the @TumorBoardTues🎩Ambassadors🎩to the world of metastatic #urothelialcancer, and🗣️the data on adjuvant pembro for high-risk MIUC RT and bring others into the discussion‼️

@PavlosMsaouel @PGrivasMDPhD @VivekSubbiah @NatureComms @FaltasLab @OAlhalabiMD @apolo_andrea @QingZhangLab @hodgeshc @drmehrarohit @neerajaiims @UroDocAsh @montypal I want to join as well!

@PGrivasMDPhD @VivekSubbiah @NatureComms @FaltasLab @OAlhalabiMD @apolo_andrea @QingZhangLab @hodgeshc @drmehrarohit @neerajaiims @UroDocAsh @montypal Thank you @PGrivasMDPhD. Should celebrate with ouzo!

Excited to share the latest #MsaouelLab collaborative effort in @NatureComms characterizing #SMARCB1 deficiency as a driver of urothelial carcinoma subsets at least in part via IL6/JAK/STAT signaling 👉nature.com/articles/s4146…